Calprotectin Leadership BDC offers the broadest calprotectin portfolio including fCAL ELISA, Quantum Blue rapid tests, and CALEX sampling devices, enabling end-to-end stool to serum calprotectin solutions for GI and inflammatory disease labs.

Product Momentum The recent sCAL turbo launch signals ongoing product expansion and readiness to meet labs seeking faster, high-throughput serum calprotectin testing, creating cross-sell opportunities with existing fCAL and future tests.

Niche Innovation A focused line of specialty assays such as Flow CAST for basophil activation, GanglioCombi for anti-Ganglioside testing, and Chronobiology melatonin assays positions BDC to sell to academic labs and specialty clinics needing unique diagnostic panels.

Local Support Edge As a North American affiliate, BDC can offer closer customer relationships, enhanced support, and tailored after-sales service, which can be a differentiator when pitching to midsize labs and hospitals.

Growth via Partnerships With a lean team and revenues in the lower mid-market, there is opportunity to expand through distributor partnerships, collaborations with universities, and cross-region sales leveraging the global BÜHLMANN network.